Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA.
Published November 29, 2017 · Recall initiated: November 6, 2017
Summary
FDA records drug Class III recall D-0093-2018, published November 29, 2017 and initiated November 6, 2017. Recalling firm: West-Ward Pharmaceuticals Corp.; Status: Terminated; Reported quantity: 16,157 shelf packs; Lot: Lot #: 106390, 106393, 106395, Exp 10/18. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
What to do
Voluntary: Firm initiated · Letter
Get an email if DEXAMETHASONE SODIUM PHOSPHATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DEXAMETHASONE SODIUM PHOSPHATE
- Manufacturer
- West-Ward Pharmaceuticals Corp.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot #: 106390, 106393, 106395, Exp 10/18
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, RxMarch 25, 2026
- FDADexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only,June 26, 2024
- FDADexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 0641-6146-01), packagedNovember 29, 2017
- FDAPravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,November 29, 2017
- FDAParoxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging,November 29, 2017
- FDADark Chocolate Almond, 12/10 oz., 12/18 oz., 18/14 oz., 8/10 oz., 12/8 oz., 8/8 oz., 18 pc.,November 29, 2017
Questions about this recall
Was Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25), Rx Only, Manufactured by WEST-WARD, Eatontown, NJ 07724 USA. recalled?
Yes. FDA published recall D-0093-2018 on November 29, 2017. Reported hazard: Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DEXAMETHASONE SODIUM PHOSPHATE.